2021
February 9, 2021
Further Innovation and Execution at ALPS and GT Clearview Capital […]
February 1, 2021
High-Efficiency, Automated Facility to Save up to 90% on water […]
January 26, 2021
ALPS and Cann Group Limited sign agreement to confirm and […]
January 19, 2021
LAS VEGAS, NV, January 19, 2021 – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) today provided the following corporate update, in line with its commitment to maintain a continuing dialogue with investors and other stakeholders on the progress and development of the Company.
January 6, 2021
LAS VEGAS, NV, January 6, 2021 – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) is hosting a conference call tomorrow, January 7, 2021 at 12:00pm ET to discuss the announced intended transactions in regards Green Therapeutics and ALPS.
January 5, 2021
LAS VEGAS, NV, January 5, 2021 – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) and 2750176 Ontario Inc. (“ALPS”) today announced that they, along with the holders of the outstanding shares of ALPS, have entered into a non-binding term sheet whereby AUSA is to acquire 51% of the issued and outstanding shares of ALPS, with an option to purchase the remaining 49%. Further details regarding the terms of the proposed transaction are set forth below.
January 5, 2021
LAS VEGAS, NV, January 5, 2020 – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) today announced that the Company has entered into a non-binding term sheet dated January 4, 2020 with Green Therapeutics LLC (“GT”) and the holders of the issued and outstanding membership interests of GT setting forth the terms of a proposed transaction pursuant to which Australis will purchase 100% of the issued and outstanding membership interests in GT. Prior to completing the acquisition, the parties have agreed to settle a previously announced legal dispute regarding the original May 2019 transaction whereby AUSA had acquired certain non-operational GT assets.